Ahmed W, Qureshi H, Alam S E, Zuberi S J
PMRC Research Centre, Jinnah Postgraduate Medical Centre, Karachi.
J Pak Med Assoc. 1995 Apr;45(4):89-91.
The efficacy of omeprazole 20 mg a day was assessed against ranitidine 150 mg twice a day in the healing and relapse of duodenal ulcer. Forty three endoscopically verified cases were allocated to 2 weeks of treatment, which was extended to 4 weeks, if the ulcer persisted on day 15. Two cases were excluded due to deviation from the protocol. Of 41 evaluable cases, 21 received omeprazole and 20 ranitidine. Healing rates with omeprazole and ranitidine at 2 weeks were 71% and 70% respectively which rose to 100% and 90% at 4 weeks (N.S). There was no significant difference in pain relief in two groups. Follow-up endoscopies, in 33 healed cases revealed 100% relapse at 3 months in omeprazole and 79% in ranitidine treated cases (P < 0.05).
在十二指肠溃疡的愈合和复发方面,对每日服用20毫克奥美拉唑与每日两次服用150毫克雷尼替丁的疗效进行了评估。43例经内镜检查证实的病例被分配接受为期2周的治疗,如果溃疡在第15天仍未愈合,则将治疗延长至4周。有2例因偏离方案而被排除。在41例可评估病例中,21例接受奥美拉唑治疗,20例接受雷尼替丁治疗。奥美拉唑组和雷尼替丁组在2周时的愈合率分别为71%和70%,在4周时分别升至100%和90%(无显著性差异)。两组在疼痛缓解方面无显著差异。对33例愈合病例进行的随访内镜检查显示,奥美拉唑治疗组在3个月时的复发率为100%,雷尼替丁治疗组为79%(P<0.05)。